Found: 3
Select item for more details and to access through your institution.
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial.
- Published in:
- Prostate, 2021, v. 81, n. 6, p. 326, doi. 10.1002/pros.24110
- By:
- Publication type:
- Article
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 794, doi. 10.1093/oncolo/oyae120
- By:
- Publication type:
- Article